See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

DHTV
Popular
Top Rated

Related Medications Videos on Diabetes Health TV

Todd speaks about Levemir

Todd Hobbs

Todd speaks about Levemir

The World's First Diabetes Emergency Kit

Gillian Miller - Diabetes and More

The World's First Diabetes Emergency Kit

A Product For When You Have Low Blood Sugar

Bill Abajian

A Product For When You Have Low Blood Sugar

Sulfonylureas

Updated 18 weeks ago
New Type 2 Drugs Change Treatment Decisions
Jan 4, 2014 | 
Metformin, the cornerstone in treating type 2 diabetes, saw an increase in usage among type 2s from 23 percent of that population in 1997 to 53 percent in 2012. But that increase has since plateaued due to the introduction of additional drugs that target insulin secretion and glucose regulation.
Common Diabetes Drugs May Carry Risk, Study Suggests
Nov 2, 2013 | 
When it comes to the treatment of type 2 diabetes, metformin may be a safer choice than sulfonylureas, according to the results of a new study.
DHTV
Popular
Top Rated

Related Medications Videos on Diabetes Health TV

Todd speaks about Levemir

Todd Hobbs

Todd speaks about Levemir

The World's First Diabetes Emergency Kit

Gillian Miller - Diabetes and More

The World's First Diabetes Emergency Kit

A Product For When You Have Low Blood Sugar

Bill Abajian

A Product For When You Have Low Blood Sugar

Novo Says Early Use of Victoza Aids Type 2 Control
Oct 2, 2011 | 
News from Danish pharmaceutical manufacturer Novo Nordisk reinforces the growing trend toward using a two-drug combination in the early treatment of type 2 diabetes. (See "A Conversation About Janumet and Earlier Combination Therapy for Type 2 Diabetes" for more discussion about this phenomenon.) In a study it released in Lisbon, Portugal, at the recent meeting of the European Association for the Study of Diabetes, Novo said that combining its recently released drug Victoza® (liraglutide) with another drug early in therapy helps recently diagnosed type 2s achieve greater blood glucose control than they can with a single drug.
Type 2s on Sulfonylureas Less Likely to Take Anti-Depressants
Jun 1, 2011 | 
Type 2 patients who use only a sulfonylurea are less likely to take anti-depressant drugs than diabetes patients on other medications. That's the conclusion of a report delivered recently in Honolulu at the annual meeting of the American Psychiatric Association.

Fatal error: Call to a member function getUrl() on a non-object in /home/diabetes/public_html/browse.php on line 54